Pharmacological characteristics of once‐weekly insulin icodec in Japanese individuals with type 1 diabetes
Icodec pharmacological properties in Japanese individuals with T1D in this study support the potential of icodec to provide basal insulin coverage with once-weekly dosing in Japanese individuals with diabetes.
Authors
- Miwa Haranaka (ORCID: https://orcid.org/0000-0001-6813-3131)
- Andrea Navarria (ORCID: https://orcid.org/0000-0001-8764-3073)
- Inge B. Halberg
- Tomoyuki Nishida (ORCID: https://orcid.org/0009-0004-5812-7167)
- Niels Rode Kristensen (ORCID: https://orcid.org/0000-0001-8582-6298)
- Stinne Byrholdt Søgaard (ORCID: https://orcid.org/0000-0002-1611-4585)
- Rasmus Ribel‐Madsen (ORCID: https://orcid.org/0000-0001-7016-3313)
- Takashi Eto
Institutions
- Novo Nordisk (Denmark) (DK)
Publication Details
- Journal
- Journal of Diabetes Investigation
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1111/jdi.14384
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Novo Nordisk